ASTRIA THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 03 Jun 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90751659
- Mark type
- Stylized text
- Filed
- 03 Jun 2021
- Published for opposition
- 20 Feb 2024
- Attorney of record
- Richard Todd Armstrong
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of allergic and inflammatory diseases and disorders; all of the foregoing do not contain cannabis, hemp, or derivatives thereof
Owner
- ASTRIA THERAPEUTICS, INC., Boston, MA, US
- ASTRIA THERAPEUTICS, INC., Boston, MA, US
- Catabasis Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 4 GRANTED
- 02 Apr 2026 — SOU EXTENSION 4 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — SOU EXTENSION 3 GRANTED
- 08 Oct 2025 — SOU EXTENSION 3 FILED
- 08 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Apr 2025 — SOU EXTENSION 2 GRANTED
- 07 Apr 2025 — SOU EXTENSION 2 FILED
- 07 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Oct 2024 — SOU EXTENSION 1 GRANTED
- 11 Oct 2024 — SOU EXTENSION 1 FILED